4D Molecular Therapeutics Inc (FDMT)

4D Molecular Therapeutics Inc (FDMT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $711M; returns 1 day -8.9%, 1 week -11.0%, 1 year +8.0%.

4D Molecular Therapeutics (4DMT) is a late-stage clinical biotechnology company specializing in targeted gene therapies using its proprietary Therapeutic Vector Evolution platform. The company's business model centers on developing a 'backbone' therapy for large-market retinal and pulmonary diseases to replace the high treatment burden of chronic injections.

Groups FDMT belongs to

• Biotechnology
• Gene Therapy
• Clinical Stage Biotech
• Ophthalmology
• Precision Medicine
• Life Sciences
• Healthcare
• Clinical Stage
• R&D

FDMT financial model: income statement, cash flow and balance sheet